DadFinStart your free week
DadFin › Stocks › Real Estate › XRN

Chiron Real Estate Inc. (XRN) stock score

Real Estate · REIT - Healthcare Facilities · United States

$33.59 ▼ -1.50% today

45.6
Dad Score, out of 100
middling

Chiron Real Estate Inc. (XRN) is a REIT - Healthcare Facilities company in the Real Estate sector, listed in the United States. On DadFin's weekly run it scores 45.6 out of 100 on the Dad Score, a middling reading that places the business ahead of 46% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Real Estate it ranks #124 of 240. Its strongest axes are valuation, growth and macro; its weakest are price action and risk.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Above average
Quality
Average
Growth
Above average
Price action
Below average
Risk
Below average
Conviction
Weak
Liquidity
Weak
Macro
Strong

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)9.1×
P/E (forward)-8.3×
Dividend yield6.63%
Return on capital4.7%
Operating margin23.2%
Revenue growth (YoY)+6.7%
FCF yield-0.6%
Net debt / EBITDA6.76×
Piotroski F-Score5 / 9
52-week change+13.2%
Market cap$492M
Next earnings—

What subscribers see on XRN

Start your free weekSubscriber? Open the full research →

REIT - Healthcare Facilities peers

StockCompanyDad ScoreBandMarket cap
WELLWelltower Inc.46.6middling$164.1B
VTRVentas, Inc.41.7middling$43.1B
OHIOmega Healthcare Investors, Inc.77.0good$14.4B
DOCHealthpeak Properties, Inc.37.7weak$13.8B
AHRAmerican Healthcare REIT, Inc.51.5middling$11.1B
CTRECareTrust REIT, Inc.29.1weak$8.6B
SBRASabra Health Care REIT, Inc.35.0weak$4.9B
NHINational Health Investors, Inc.82.4good$3.2B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.